| 名称: | |
| 描述: | |
| 公开/私有: | 公开 私有 |
标签:
用空格间隔多个标签,如:小说 文学 余秋雨
保存至书单:
封面仅供参考
Biomarkers in carcinoma of unknown primary / |
|
|
ISBN/ISSN:
|
9783030844318 价格： CNY1641.39 |
|
ISBN/ISSN:
|
3030844315 |
|
科图分类法:
|
R73 |
|
题名:
|
Biomarkers in carcinoma of unknown primary / |
|
版次:
|
2022 edition. |
|
出版发行:
|
Cham, Switzerland : Springer, 2022. |
|
载体形态:
|
483 pages ; ; 26 cm |
|
附注:
|
Includes index. |
|
内容提要:
|
This book aims to examine all immunohistochemical and molecular pathological biomarkers that can be useful and effective in patient diagnosis, prognosis and treatment decision, especially when faced with a carcinoma of unknown primary. For this purpose, epithelial malignancies of all systems and related biomarkers are examined one by one, and to look at the subject through the metastatic regions window, biomarkers that can be used to determine the primary focus for carcinomas seen in the areas most frequently metastasized are emphasized. With this bi-directional perspective, the reader is able to find biomarkers of any type of carcinoma on a system basis, as well as access to which biomarkers can be used when faced with a metastatic carcinoma. The importance of biomarkers in patient follow-up and treatment is also conveyed through the clinician's eye, and so biomarkers are handled with a holistic approach in all aspects. This book primarily targets pathologists, as well as clinicians (oncologists and surgeons) who manage cancer patients. |
|
主题词:
|
Cancer Molecular aspects. |
|
主题词:
|
Biochemical markers. |
|
主要责任者:
|
Sarioglu, Sulen, |
|
主要责任者:
|
Sagol, Ozgul, |
|
主要责任者:
|
Aysal, Anil, |
|
标签:
|
|
|
相关主题:
|
|
|
相关资源:
|
|
限定所在馆:
限定所在馆藏地点:
限定馆藏状态:
预约：可预约已外借图书，在馆图书不可预约
>>
HEA| |03155cam 2200313 450 001| |022022007710 008| |220105s2022 sz 001 0 eng d 020| |▼a9783030844318▼qhardcover▼cCNY1641.39 020| |▼a3030844315▼qhardcover 020| |▼z9783030844325▼qelectronic book 020| |▼z3030844323▼qelectronic book 040| |▼aYDX▼beng▼erda▼cYDX▼dGW5XE▼dYDX▼dEBLCP 082|04|▼a616.99/40421▼223 090| |▼aR73▼b232452 245|00|▼aBiomarkers in carcinoma of u- | |nknown primary /▼cSulen Sariog- | |lu, Ozgul Sagol, Anil Aysal, editors. 250| |▼a2022 edition. 260| |▼aCham, Switzerland :▼bSpringer,▼c2022. 300| |▼a483 pages ;▼c26 cm 336| |▼atext▼btxt▼2rdacontent 337| |▼aunmediated▼bn▼2rdamedia 338| |▼avolume▼bnc▼2rdacarrier 500| |▼aIncludes index. 505|0 |▼aChapter 1) Definition of Tis- | |sue-based Biomarkers Its Place- | | in Medicine and Molecular Pat- | |hology －－ Chapter 2) The Conce- | |pt and Mechanisms of Metastasi- | |s －－ Chapter 3) Biomarkers in - | |Skin Carcinomas －－ Chapter 4) - | |Biomarkers in Head and Neck Ca- | |rcinomas －－ Chapter 5) Biomark- | |ers in Pulmonary Carcinomas －－- | | Chapter 6) Biomarkers in Endo- | |crine Organ Carcinomas －－ Chap- | |ter 7) Biomarkers in Gastroint- | |estinal System Carcinomas －－ C- | |hapter 8) Biomarkers in Hepato- | |pancreatobiliary Carcinomas －－- | | Chapter 9) Biomarkers in Urin- | |ary Tract and Male Genital Sys- | |tem Carcinomas －－ Chapter 10) - | |Biomarkers in Gynecological Ca- | |rcinomas －－ Chapter 11) Biomar- | |kers in Breast Carcinomas －－ C- | |hapter 12) Diagnostic Approach- | | According to More Frequent Me- | |tastatic Sites-Liver, Lungs, B- | |one, Lymph Nodes －－ Chapter 13- | |) Diagnostic Approach Accordin- | |g to Uncovered Metastatic Site- | |s - Mediastinum-Timus, Periton- | |eum, Central Nervous System, S- | |oft Tissue －－ Chapter 14) Mana- | |gement of the Patients with Pr- | |imary Unknown Carcinoma and th- | |e Role of Biomarkers －－ Chapte- | |r 15) Treatment Approach to Ca- | |rcinomas of Unknown Primary －－ Appendix. 520| |▼aThis book aims to examine al- | |l immunohistochemical and mole- | |cular pathological biomarkers - | |that can be useful and effecti- | |ve in patient diagnosis, progn- | |osis and treatment decision, e- | |specially when faced with a ca- | |rcinoma of unknown primary. Fo- | |r this purpose, epithelial mal- | |ignancies of all systems and r- | |elated biomarkers are examined- | | one by one, and to look at th- | |e subject through the metastat- | |ic regions window, biomarkers - | |that can be used to determine - | |the primary focus for carcinom- | |as seen in the areas most freq- | |uently metastasized are emphas- | |ized. With this bi-directional- | | perspective, the reader is ab- | |le to find biomarkers of any t- | |ype of carcinoma on a system b- | |asis, as well as access to whi- | |ch biomarkers can be used when- | | faced with a metastatic carci- | |noma. The importance of biomar- | |kers in patient follow-up and - | |treatment is also conveyed thr- | |ough the clinician\'s eye, and - | |so biomarkers are handled with- | | a holistic approach in all as- | |pects. This book primarily tar- | |gets pathologists, as well as - | |clinicians (oncologists and su- | |rgeons) who manage cancer patients. 650| 0|▼aCancer▼xMolecular aspects. 650| 0|▼aBiochemical markers. 700|1 |▼aSarioglu, Sulen,▼eeditor. 700|1 |▼aSagol, Ozgul,▼eeditor. 700|1 |▼aAysal, Anil,▼eeditor.